½ÃÀ庸°í¼­
»óǰÄÚµå
1301165

¹Ì±¹ÀÇ ¿Ü¿ë ÁøÅëÁ¦ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : Á¦Ç°º°(¿Â¿­/³Ã°¨ Á¦Ç°, Ű³×½Ã¿Ã·ÎÁö Å×ÀÌÇÁ, TENS ±â±â, Àû»ö±¤¼±¿ä¹ý/Àû¿Ü¼±¿ä¹ý Á¦Ç°), À¯Åë ä³Îº°, ºÎ¹®º° ¿¹Ãø(2023-2030³â)

U.S. External Analgesics Market Size, Share & Trends Analysis Report By Product (Hot/Cold Products, Kinesiology Tape, TENS Devices, Red Light Therapy/ Infrared Therapy Products), By Distribution Channel, And Segment Forecasts, 2023 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 100 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¹Ì±¹ÀÇ ¿Ü¿ë ÁøÅëÁ¦ ½ÃÀå ¼ºÀå ¹× µ¿Çâ

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é ¹Ì±¹ÀÇ ¿Ü¿ë ÁøÅëÁ¦ ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 67¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç ¿¹Ãø ±â°£ Áß CAGRÀº 13.3%¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸¸¼ºÁúȯ À¯º´·ü Áõ°¡, ÀÔ¿øÀϼö ´ÜÃà¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ¹Ì±¹³» ±â¼ú ¹ßÀüÀÌ ¹Ì±¹ÀÇ ¿Ü¿ë ÁøÅëÁ¦ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.

¹Ì±¹¿¡¼­´Â ÇコÄÉ¾î »ê¾÷À» Çü¼ºÇÏ´Â ´Ù¾çÇÑ ¿äÀÎÀ¸·Î ÀÎÇØ ÀÔ¿ø ±â°£ ´ÜÃà¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Áß¿äÇÑ ÃËÁø¿äÀÎ Áß Çϳª´Â º´¿ø°ú ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ°¡ ÀÚ¿ø Ȱ¿ëÀ» ÃÖÀûÈ­ÇÏ°í ºñ¿ëÀ» Àý°¨Çϱâ À§ÇØ ³ë·ÂÇÏ´Â °¡¿îµ¥, ºñ¿ë Àý°¨¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù. Àå±â ÀÔ¿øÀº ÀÇ·á ºñ¿ëÀ» Áõ°¡½Ãų »Ó¸¸ ¾Æ´Ï¶ó ȯÀÚ¸¦ ÇÕº´Áõ°ú °¨¿°ÀÇ À§Çè¿¡ ³ëÃâ½Ãų ¼ö ÀÖ½À´Ï´Ù. µû¶ó¼­ ƯÁ¤ Ä¡·á¿Í ¼­ºñ½º¸¦ °¡´ÉÇÑ ÇÑ ÀÔ¿ø½Ç¿¡¼­ ¿Ü·¡·Î ¿Å±â´Â °Í¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.

ÀÌ·¯ÇÑ ÀÔ¿ø Àϼö ´ÜÃà¿¡ ´ëÇÑ ¼ö¿äÀÇ Áõ°¡°¡ ¿¹Ãø ±â°£ Áß ÅëÁõ °ü¸® ±â±â ½ÃÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ValuePenguinÀÇ 2022³â ¹ßÇ¥¿¡ µû¸£¸é ¹Ì±¹ º´¿øÀÇ Æò±Õ ÀÔ¿ø ±â°£Àº ¾à 4.6ÀÏÀ̸ç, 1ÀÏ´ç Æò±Õ ºñ¿ëÀº 2,873´Þ·¯(USD)¿¡ ´ÞÇÏ´Â °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ³ôÀº ÀÔ¿ø ºñ¿ëÀ¸·Î ÀÎÇØ ÀÔ¿ø ±â°£ ´ÜÃà°ú ºñ¿ë È¿À²ÀûÀÎ Ä¡·á ȯ°æÀ¸·ÎÀÇ ÀüȯÀÌ ÇÊ¿äÇϸç, ÅëÁõ °ü¸® ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº ¹Ì±¹ÀÇ ¿Ü¿ë ÁøÅëÁ¦ ½ÃÀå »óȲ¿¡ Å« ¿µÇâÀ» ¹ÌÃÆÀ¸¸ç, ÅëÁõ °ü¸®¸¦ À§ÇÑ »õ·Ó°í Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀ» Á¦°øÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº ¿Ü¿ë ÁøÅëÁ¦ÀÇ °³¹ß, ó¹æ ¹× Åõ¿© ¹æ½Ä¿¡ Çõ¸íÀ» ÀÏÀ¸ÄÑ À¯È¿¼º, ÆíÀǼº ¹× ȯÀÚ °á°ú °³¼±À¸·Î À̾îÁö°í ÀÖ½À´Ï´Ù.

COVID-19 Àü¿°º´Àº ¹Ì±¹ÀÇ ¿Ü¿ë ÁøÅëÁ¦ ½ÃÀåÀ» Æ÷ÇÔÇÑ ´Ù¾çÇÑ »ê¾÷¿¡ Å« ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ´ÙÀ½Àº Àü¿°º´ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ ´ëÇÑ ¿äÁ¡ÀÌ´Ù: COVID-19 ÆÒµ¥¹ÍÀ¸·Î ¹Ì±¹¿¡¼­ ¿Ü¿ë ÁøÅëÁ¦¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇß½À´Ï´Ù. ÀÌ´Â Áý¿¡¼­ Ä¡·áÇÏ´Â ¹æ¹ýÀÇ Ã¤ÅÃÀÌ Áõ°¡Çß°í, ¹®À» ´Ý°í ÀÚ°¡°Ý¸®ÇÏ´Â µî ÀÚ°¡ °ü¸®ÀÇ ½ÇõÀÌ Áõ°¡Ç߱⠶§¹®ÀÔ´Ï´Ù.

¹Ì±¹ÀÇ ¿Ü¿ëÁøÅëÁ¦ ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

  • Á¦Ç°º°·Î´Â ÀÚ¿¬½º·´°í ÀÚ°¡ °ü¸® °¡´ÉÇÑ ÅëÁõ °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ ¿Â¿­/³Ã°¨ Á¦Ç° ºÐ¾ß°¡ 2022³â °¡Àå Å« ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
  • À¯Åë ä³Îº°·Î´Â ¼Ò¸Å/½Ç¹° ¸ÅÀåÀÌ 2022³â ½ÃÀåÀ» ÁÖµµÇß½À´Ï´Ù. ¼ÒºñÀÚµéÀº ÀϹÝÀûÀ¸·Î ÀÌ·¯ÇÑ Á¦Ç°µéÀ» ¿ÀÇÁ¶óÀÎ ¸ÅÀå¿¡¼­ Á÷Á¢ º¸°í ±¸¸ÅÇÏ´Â °ÍÀ» ¼±È£Çϱ⠶§¹®ÀÔ´Ï´Ù. ¶ÇÇÑ E-Commerce´Â ¿¹Ãø ±â°£ Áß °¡Àå ºü¸¥ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • 2021³â 1¿ù, È­ÀÌÀÚ´Â ÇÁ¸®¹Ì¾î¿Í Çù·ÂÇÏ¿© ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ¿¡°Ô 5°¡Áö Áß¿äÇÑ ÀǾàǰÀ» Á¦°øÇÏ¿© ȯÀÚ Ä¡·á¿¡ ÇÊ¿äÇÑ ÀǾàǰÀÇ ±ä±ÞÇÑ ¼ö¿ä¸¦ ÃæÁ·½ÃÄ×½À´Ï´Ù.
  • 2023³â 5¿ù, ¹Ú½ºÅÍ´Â ¹ÙÀÌ¿ÀÁ¦¾à ¼Ö·ç¼Ç »ç¾÷À» »ç¸ðÆÝµå ÅõÀÚȸ»çÀÎ ¿ö¹ö±× ÇÉÄ¿½º(Warburg Pincus)¿Í ¾îµåº¥Æ® ÀÎÅͳ»¼Å³Î(Advent International)¿¡ ¸Å°¢ÇÏ´Â ±¸¼Ó·Â ÀÖ´Â °è¾àÀ» ü°áÇß´Ù°í ¹àÇû½À´Ï´Ù. ÀÌ °è¾à¿¡ µû¶ó Baxter´Â 42¾ï 5,000¸¸ ´Þ·¯ÀÇ Çö±Ý Áö±ÞÀ» ¹ÞÀ» ±Ç¸®°¡ ÀÖÀ¸¸ç, °ü·ÊÀûÀÎ ¸¶°¨ Á¶Á¤ÀÌ ÀÌ·ç¾îÁú ¿¹Á¤ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

  • ½ÃÀå ¼¼ºÐÈ­¿Í ¹üÀ§
  • Á¶»ç ¹üÀ§¿Í ÀüÁ¦Á¶°Ç
  • Á¶»ç ¹æ¹ý
  • Á¶»ç ¹æ¹ý ÇÁ·¹ÀÓ¿öÅ©
  • Á¶»ç ¿öÅ©Ç÷οì
  • Á¤º¸ Á¶´Þ
    • ±¸ÀÔÇÑ µ¥ÀÌÅͺ£À̽º
    • GVRÀÇ ³»ºÎ µ¥ÀÌÅͺ£À̽º
    • 2Â÷ Á¤º¸ :
    • Á¦»ïÀÚÀÇ ½ÃÁ¡ :
    • 1Â÷ Á¶»ç
  • Á¤º¸ ºÐ¼® ¹× µ¥ÀÌÅÍ ºÐ¼® ¸ðµ¨
    • ½ÃÀå Çü¼º°ú °ËÁõ
  • µ¥ÀÌÅÍ ¼Ò½º ¸®½ºÆ®

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ¹Ì±¹ÀÇ ¿Ü¿ë ÁøÅëÁ¦ ½ÃÀå ½º³À¼ô
  • ºÎ¹® ½º³À¼ô
  • °æÀï ±¸µµ ½º³À¼ô

Á¦3Àå ¹Ì±¹ÀÇ ¿Ü¿ë ÁøÅëÁ¦ ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
    • ¸ð½ÃÀå ºÐ¼®
    • º¸Á¶ÀûÀÎ ½ÃÀå ºÐ¼®
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
  • ¹Ì±¹ÀÇ ¿Ü¿ë ÁøÅëÁ¦ ½ÃÀå ºÐ¼® Åø
    • ¹Ì±¹ÀÇ ¿Ü¿ë ÁøÅëÁ¦ ½ÃÀå - PESTLE ºÐ¼®
    • ¹Ì±¹ÀÇ ¿Ü¿ë ÁøÅëÁ¦ ½ÃÀå - PorterÀÇ »ê¾÷ ºÐ¼®
  • COVID-19¿¡ ÀÇÇÑ ¹Ì±¹ÀÇ ¿Ü¿ë ÁøÅëÁ¦ ½ÃÀå¿¡ ´ëÇÑ ¿µÇâ

Á¦4Àå ¹Ì±¹ÀÇ ¿Ü¿ë ÁøÅëÁ¦ ½ÃÀå : Á¦Ç° ÃßÁ¤¡¤µ¿Ç⠺м®

  • ¹Ì±¹ÀÇ ¿Ü¿ë ÁøÅëÁ¦ ½ÃÀå : Á¦Ç° º¯µ¿ ºÐ¼®, 2022³â ¹× 2030³â 100¸¸ ´Þ·¯
  • ½ÃÀåÀÇ Á¤ÀÇ¿Í ¹üÀ§
  • ¿Â¿­/³Ã°¨ Á¦Ç°
    • ¿Â¿­/³Ã°¨ Á¦Ç° ½ÃÀå Ã߻ꡤ¿¹Ãø, 2018-2030³â(100¸¸ ´Þ·¯)
    • ÀÏȸ¿ë¿Â³Ã ǰ ½ÃÀå Ã߻ꡤ¿¹Ãø, 2018-2030(100¸¸ ´Þ·¯)
    • ºñÀÏȸ¿ë¿Â³Ã ǰ ½ÃÀå Ã߻ꡤ¿¹Ãø, 2018-2030³â(100¸¸ ´Þ·¯)
  • Ű³×½Ã¿Ã·ÎÁö Å×ÀÌÇÁ
    • Ű³×½Ã¿Ã·ÎÁö Å×ÀÌÇÁ ½ÃÀå Ã߻ꡤ¿¹Ãø, 2018-2030³â(100¸¸ ´Þ·¯)
  • °¡¿­ ÆÐµå
    • ¿Â¿­ ÆÐµå ½ÃÀå Ã߻ꡤ¿¹Ãø, 2018-2030(100¸¸ ´Þ·¯)
  • Àû»ö ±¤¼±¿ä¹ý/Àû¿Ü¼±¿ä¹ý Á¦Ç°
    • Àû»ö ±¤¼±¿ä¹ý/Àû¿Ü¼±¿ä¹ý Á¦Ç° ½ÃÀå Ã߻ꡤ¿¹Ãø, 2018-2030³â(100¸¸ ´Þ·¯)
  • TENS ±â±â
    • TENS ±â±â ½ÃÀå Ã߻ꡤ¿¹Ãø, 2018-2030³â(100¸¸ ´Þ·¯)

Á¦5Àå ¹Ì±¹ÀÇ ¿Ü¿ë ÁøÅëÁ¦ ½ÃÀå : À¯Åë ä³Î ÃßÁ¤¡¤µ¿Ç⠺м®

  • ¹Ì±¹ÀÇ ¿Ü¿ë ÁøÅëÁ¦ ½ÃÀå : À¯Åë ä³Î º¯µ¿ ºÐ¼®, 2022³â ¹× 2030³â 100¸¸ ´Þ·¯
  • ½ÃÀåÀÇ Á¤ÀÇ¿Í ¹üÀ§
    • ¼Ò¸Å/½ÇÁ¡Æ÷
    • E-Commerce
    • ±âŸ
  • ¼Ò¸Å/½ÇÁ¡Æ÷
    • ¼Ò¸Å/½ÇÁ¡Æ÷ ½ÃÀå Ã߻ꡤ¿¹Ãø, 2018-2030³â(100¸¸ ´Þ·¯)
  • E-Commerce
    • E-Commerce ½ÃÀå Ã߻ꡤ¿¹Ãø, 2018-2030³â(100¸¸ ´Þ·¯)
  • ±âŸ
    • ±âŸ ½ÃÀå Ã߻ꡤ¿¹Ãø, 2018-2030(100¸¸ ´Þ·¯)

Á¦6Àå °æÀï ±¸µµ°ú ºÐ¼®

  • ÁÖ¿ä ½ÃÀå Âü¿© ±â¾÷¿¡ ÀÇÇÑ ÃÖ±Ù µ¿Çâ°ú ¿µÇ⠺м®
  • ±â¾÷ÀÇ ½ÃÀå ÇöȲ ºÐ¼®
  • ±â¾÷/°æÀïÀÇ ºÐ·ù(ÁÖ¿ä À̳뺣ÀÌÅÍ, ½ÃÀå ¸®´õ, ½Å±Ô ±â¾÷)
  • ±â¾÷ °³¿ä
    • Baxter's
    • Boston Scientific Corporation
    • Enovis
    • Medtronic
    • ICU Medical, Inc.
    • Abbott
    • Stryker
    • Nevro Corp.
    • OMRON Healthcare
KSA 23.07.24

U.S. External Analgesics Market Growth & Trends

The U.S. external analgesics market size is expected to reach USD 6.7 billion by 2030, exhibiting a CAGR of 13.3% during the forecast period according to a new report by Grand View Research, Inc. Increasing incidence of chronic illness, increased demand for reduced hospital stays, and rising technological advancement in the country are driving the growth of external analgesics market in U.S.

The demand for reduced hospital stays is increasing in the U.S. due to various factors shaping the healthcare industry. One significant driver is the growing emphasis on cost containment, which is compelling hospitals and healthcare providers to optimize resource utilization and reduce expenses. Prolonged hospital stays not only increase healthcare costs but also expose patients to a higher risk of complications and infections. Consequently, there is a growing focus on shifting certain treatments and services from inpatient to outpatient settings whenever possible.

This growing demand for shorter hospital stays is expected to drive the market for pain management devices over the forecast period. The average length of stay in U.S. hospitals is approximately 4.6 days, with each day costing an average of USD 2,873, as per a 2022 article published by ValuePenguin. The high costs of hospitalization have amplified the need for shorter stays and a shift toward more cost-effective care settings, leading to an increased demand for pain management devices.

Technological advancements have significantly influenced the landscape of the U.S. external analgesics market, bringing about new and innovative solutions for pain management. These advancements have revolutionized the way external analgesics are developed, formulated, and administered, leading to improved effectiveness, convenience, and patient outcomes.

The COVID-19 pandemic has had a significant impact on various industries, including the U.S. external analgesics market. Here are some key points regarding the influence of the pandemic on the market: The COVID-19 pandemic has led to a surge in demand for external analgesics in the U.S. This can be attributed to factors such as the rise in the adoption of home-based remedies and self-care practices during lockdowns and restrictions.

U.S. External Analgesics Market Report Highlights

  • Based on product, the hot/cold products segment accounted for the largest revenue share in 2022 owing to growing demand for natural and self-directed pain management solutions.
  • On the basis of distribution channel, retail/brick-and-mortar dominated the market in 2022, because consumers typically prefer to browse and purchase these products in stores physically. Further, e-commerce is expected to grow at the fastest CAGR of during the forecast period.
  • In January 2021, Pfizer joined forces with Premier to provide healthcare providers with five crucial medications to meet the immediate need for medication necessary for patient care.
  • In May 2023, Baxter has recently disclosed the execution of a binding contract to divest its BioPharma Solutions business to Warburg Pincus and Advent International, recognized private equity investment firms. The agreement stipulates that Baxter will be entitled to a cash payment of USD 4.25 billion, subject to customary closing adjustments.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation and Scope
  • 1.2 Research Scope and Assumptions
  • 1.3 Research Methodology
  • 1.4 Research Methodology Framework
  • 1.5 Research Workflow
  • 1.6 Information Procurement
    • 1.6.1 Purchased Database
    • 1.6.2 GVR's Internal Database
    • 1.6.3 Secondary sources:
    • 1.6.4 Third Party Perspective:
    • 1.6.5 Primary Research
  • 1.7 Information Analysis & Data Analysis Models
    • 1.7.1 Market Formulation & Validation
  • 1.8 List to Data Sources

Chapter 2 Executive Summary

  • 2.1 U.S. External Analgesics Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Competitive Landscape Snapshot

Chapter 3 U.S. External Analgesics Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Analysis
    • 3.1.2 Ancillary Market Analysis
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Analysis
    • 3.2.2 Market Restraint Analysis
  • 3.3 U.S. External Analgesics Market Analysis Tools
    • 3.3.1 U.S. External ANalgesics market - PESTLE Analysis
      • 3.3.1.1 Political & Legal Landscape
      • 3.3.1.2 Economic Landscape
      • 3.3.1.3 Social Landscape
      • 3.3.1.4 Technology Landscape
    • 3.3.2 U.S. External ANalgesics market- Porter's Analysis
      • 3.3.2.1 Supplier Power: Moderate
      • 3.3.2.2 Buyer Power: Moderately high
      • 3.3.2.3 Substitution Threat: Moderate
      • 3.3.2.4 Threat of New Entrants: Moderate
      • 3.3.2.5 Competitive Rivalry: High
  • 3.4 COVID-19 Impact on U.S. External Analgesics Market

Chapter 4 U.S. External Analgesics Market: Product Estimates & Trend Analysis

  • 4.1 U.S. External Analgesics Market: Product Movement Analysis, 2022 & 2030 USD Million
  • 4.2 Market Definition and Scope
  • 4.3 Hot/Cold Products
    • 4.3.1 Hot/Cold Products market estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2 Disposable Hot/Cold Products market estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3 Non-disposable Hot/cold Products market estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4 Kinesiology Tape
    • 4.4.1 Kinesiology tape market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5 Heating Pads
    • 4.5.1 Heating pads market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.6 Red Light Therapy/ Infrared Therapy Products
    • 4.6.1 Red light therapy/ infrared therapy products market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.7 TENS Devices
    • 4.7.1 TENS Devices market estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5 U.S. External Analgesics Market: Distribution Channel Estimates & Trend Analysis

  • 5.1 U.S. External Analgesics Market: Distribution Channel Movement Analysis, 2022 & 2030 USD Million
  • 5.2 Market Definition and Scope
    • 5.2.1 Retail/ Brick & Mortar
    • 5.2.2 e-Commerce
    • 5.2.3 Others
  • 5.3 Retail/ Brick & Mortar
    • 5.3.1 Retail/ Brick & mortar market estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4 E-Commerce
    • 5.4.1 E-Commerce market estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5 Others
    • 5.5.1 Others market estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6 Competitive Landscape and Analysis

  • 6.1 Recent Developments & Impact Analysis, by Key Market Participants
  • 6.2 Company Market Position Analysis
  • 6.3 Company/ Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
  • 6.4 Company Profiles
    • 6.4.1 Baxter's
    • 6.4.2 Boston Scientific Corporation
    • 6.4.3 Enovis
    • 6.4.4 Medtronic
    • 6.4.5 ICU Medical, Inc.
    • 6.4.6 Abbott
    • 6.4.7 Stryker
    • 6.4.8 Nevro Corp.
    • 6.4.9 OMRON Healthcare
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦